Infectious Disease
Herpes Zoster
60
Pipeline Programs↗
37
Active Trials↗
36
Companies Involved↗
Herpes Zoster is a moderately active landscape with 60 programs across 36 companies. The most active players are Immorna Biotherapeutics, Inc., Suzhou Abogen Biosciences Co., Ltd., Centrexion Therapeutics. 13 therapies are approved with 12 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical9
Phase 18
Phase 218
Analysis
Modality Breakdown
74programs
Small molecule4358%
Vaccine3142%
Modality classified for 100% of 93 pipeline programs.
Analysis
Trial Status
102
clinical trials
Completed54 · 53%
Recruiting21 · 21%
Active, not recruiting8 · 8%
Not yet recruiting8 · 8%
Unknown status7 · 7%
Terminated4 · 4%
Clinical Trials
Trial Activity
102 trials
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07307170·750 enrolled
Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
Recruiting·—·Phase 2·NCT06978192·92 enrolled
The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07370389·750 enrolled
The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07361809·750 enrolled
The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07307976·750 enrolled
Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia
Recruiting·—·N/A·NCT06969417·50 enrolled
High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia
Recruiting·—·Phase 4·NCT06959147·46 enrolled
The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07378046·750 enrolled
The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07370402·750 enrolled
The Analgesic Efficacy and Safety of Venlafaxine in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07361796·750 enrolled
Page 1 of 7
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)